A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity
- PMID: 29236995
- DOI: 10.1093/ejcts/ezx418
A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity
Abstract
Objectives: The incidence of small-sized pulmonary adenocarcinomas with ground-glass opacity (GGO) has recently increased, with excellent postoperative prognosis. The limited resection of such cancers has been deemed to be acceptable based on retrospective studies. We conducted a prospective multi-institutional study evaluating the validity of limited resection for small-sized pulmonary adenocarcinoma with GGO.
Methods: The inclusion criteria were 25-80 years of age, no prior treatment, a maximum tumour diameter of 8-20 mm, a GGO ratio of ≥ 80%, clinical T1N0M0, lower 18F-fluorodeoxyglucose accumulation than the mediastinum, resectable by sublobar resection, pulmonary lobectomy tolerable and an intraoperative pathological diagnosis of bronchiloalveolar carcinoma. Wedge resection was preferred, but segmentectomy was permitted. Disease-specific survival and overall survival were analysed.
Results: From November 2006 to April 2012, 73 patients were enrolled from 13 institutions. One patient was ineligible, and the remaining 72 patients were preregistered. The tumours of 3 and 14 patients were intraoperatively diagnosed as benign lesions and adenocarcinomas with mixed subtype, respectively. Intraoperative cytological/histological examination of surgical margin was not performed in 2 patients, and the remaining 53 patients were ultimately eligible for this study. The mean tumour size was 14.0 mm and the mean GGO ratio was 95.9%. Thirty-nine and 14 patients underwent wedge resection and segmentectomy, respectively. Although all tumours were intraoperatively diagnosed as bronchioloalveolar carcinomas, 6 were ultimately diagnosed as adenocarcinoma with a mixed subtype. No completion lobectomy was performed. As of 1 May 2017, no recurrence of the original lung cancer was observed during 60.0-126.3 months after surgery. Two patients died from other diseases. The 5-year disease-specific and overall survival rates were 100% and 98.1%, respectively. The reduction in the pulmonary function after limited resection was minimal.
Conclusions: With these criteria, limited resection was performed safely without any recurrence, and the postoperative pulmonary function was well preserved. The outcomes of limited resection for small-sized lung cancer with GGOs that met the criteria of this study were satisfactory.
Comment in
-
Strategy of intentional limited resection for lung adenocarcinoma in situ.J Thorac Dis. 2018 Jun;10(Suppl 17):S2018-S2021. doi: 10.21037/jtd.2018.05.41. J Thorac Dis. 2018. PMID: 30023107 Free PMC article. No abstract available.
Similar articles
-
A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancer.Sci Rep. 2024 Sep 11;14(1):21243. doi: 10.1038/s41598-024-72248-8. Sci Rep. 2024. PMID: 39261621 Free PMC article.
-
Surgical treatments for multiple primary adenocarcinoma of the lung.Ann Thorac Surg. 2004 Oct;78(4):1194-9. doi: 10.1016/j.athoracsur.2004.03.102. Ann Thorac Surg. 2004. PMID: 15464469 Review.
-
Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination.Ann Thorac Surg. 2009 Oct;88(4):1106-11. doi: 10.1016/j.athoracsur.2009.06.051. Ann Thorac Surg. 2009. PMID: 19766789 Clinical Trial.
-
Curative wedge resection for non-invasive bronchioloalveolar carcinoma.Tohoku J Exp Med. 2009 Feb;217(2):133-7. doi: 10.1620/tjem.217.133. Tohoku J Exp Med. 2009. PMID: 19212106
-
Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.Ann Thorac Surg. 2004 Nov;78(5):1728-33. doi: 10.1016/j.athoracsur.2004.05.017. Ann Thorac Surg. 2004. PMID: 15511463 Review.
Cited by
-
Feasibility of intraoperative diagnosis of lung adenocarcinoma in situ to avoid excessive resection.J Thorac Dis. 2021 Mar;13(3):1338-1346. doi: 10.21037/jtd-20-2710. J Thorac Dis. 2021. PMID: 33841927 Free PMC article.
-
The Epidemiology of Ground Glass Opacity Lung Adenocarcinoma: A Network-Based Cumulative Meta-Analysis.Front Oncol. 2020 Jul 21;10:1059. doi: 10.3389/fonc.2020.01059. eCollection 2020. Front Oncol. 2020. PMID: 32793469 Free PMC article.
-
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.J Thorac Dis. 2022 Jun;14(6):2387-2411. doi: 10.21037/jtd-21-1825. J Thorac Dis. 2022. PMID: 35813753 Free PMC article. Review.
-
A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancer.Sci Rep. 2024 Sep 11;14(1):21243. doi: 10.1038/s41598-024-72248-8. Sci Rep. 2024. PMID: 39261621 Free PMC article.
-
Percutaneous Electromagnetic Transthoracic Nodule Localization for Ground Glass Nodules.J Chest Surg. 2021 Dec 5;54(6):494-499. doi: 10.5090/jcs.21.035. J Chest Surg. 2021. PMID: 34857672 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous